SCHEMBL4750798

SCHEMBL4750798

Cc1ccc2ccccc2c1CN1CCN(Cc2ccc3c(c2)OCO3)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.56
ALDH1A1 P00352 3/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
LMNA P02545 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.53
HSD17B10 Q99714 2/20 0.53
USP2 O75604 4/20 0.53
TSHR P16473 3/20 0.53
MAPK1 P28482 3/20 0.53
GAA P10253 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
POLB P06746 1/20 0.52
MAPT P10636 1/20 0.52
RAB9A P51151 1/20 0.52
CYP2D6 P10635 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
HTR1A P08908 1/20 0.51
ADRA2A P08913 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4753312 0.80 SIGMAR1 (0.55) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL108678 0.78 KDM4E (0.70) KDM4EMEN1KMT2AHSD17B10USP2
SCHEMBL2316901 0.77 CYP2D6 (0.82) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL8916005 0.75 HTT (0.67) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL2056152 0.74 KDM4E (0.62) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL13062752 0.74 ALDH1A1 (0.64) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL20149549 0.74 CRHBP (0.68) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL8229803 0.73 NCF1 (0.71) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL13007677 0.73 KDM4E (0.58) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL27683423 0.73 KDM4E (0.60) KDM4EALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO claimed
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO disclosed